{"id":"NCT03268811","sponsor":"Shire","briefTitle":"A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302","officialTitle":"A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Japanese Pediatric Subjects With Short Bowel Syndrome Who Completed SHP633-302","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-08-23","primaryCompletion":"2021-11-02","completion":"2021-11-02","firstPosted":"2017-08-31","resultsPosted":"2022-05-24","lastUpdate":"2022-05-24"},"enrollment":9,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Short Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Teduglutide","otherNames":[]}],"arms":[{"label":"Teduglutide","type":"EXPERIMENTAL"}],"summary":"The purpose of this clinical study is to evaluate the long-term safety and tolerability of teduglutide treatment in Japanese pediatric participants with short bowel syndrome (SBS) who completed Study SHP633-302 (NCT02980666).","primaryOutcome":{"measure":"Number of Participants With Treatment-emergent Adverse Events (TEAEs)","timeFrame":"From Baseline up to follow-up (up to 50 months)","effectByArm":[{"arm":"Total Children (Aged: 1 to 15 Years)","deltaMin":7,"sd":null},{"arm":"Infants (Corrected Gestational Age: 4 to < 12 Months)","deltaMin":2,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":null},"locations":{"siteCount":6,"countries":["Japan"]},"refs":{"pmids":["37364133"],"seeAlso":["https://clinicaltrials.takeda.com/study-detail/5f6b5fd94db2bf003ab470dd"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":7},"commonTop":["Viral upper respiratory tract infection","Pyrexia","Dehydration","Rash","Constipation"]}}